Sun Pharmaceutical Industries sees highest filings and grants during August in Q3 2023

Sun Pharmaceutical Industries has been focused on protecting inventions in United States(US) with 15 publications in Q3 2023

The United States(US) Patent Office dominates the patent filings and grants with nearly 33% filings and 24% grants. The United States(US), World Intellectual Property Organization(WIPO), European Patent Office(EPO), and Australia(AU) patent Office are among the top ten patent offices where Sun Pharmaceutical Industries is filings its patents. Among the top granted patent authorities, Sun Pharmaceutical Industries has 29% of its grants in Canada(CA), 24% in United States(US), and 10% in European Patent Office(EPO).

Amgen could be the strongest competitor for Sun Pharmaceutical Industries

Amgen and Johnson & Johnson secured the top positions according to recent patent publication data.

Patents related to climate change and agricultural biotechnology lead Sun Pharmaceutical Industries’s portfolio

Sun Pharmaceutical Industries has the highest number of patents in climate change followed by, agricultural biotechnology and genetically modified organism (GMO). For climate change, nearly 17% of patents were filed and 0% of patents were granted in Q3 2023.

Diabetes related patents lead Sun Pharmaceutical Industries portfolio followed by mobiles, hand-helds, pdas, smartphones, and obesity

Sun Pharmaceutical Industries has highest number of patents in diabetes followed by mobiles, hand-helds, pdas, smartphones, obesity, hyperlipidemia and type 2 diabetes. For diabetes, nearly 6% of patents were filed and 0% of patents were granted in Q3 2023.

For comprehensive analysis of Sun Pharmaceutical Industries‘s filings and grants, buy the databook here.

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.